{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:35:29Z","timestamp":1761100529676},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,1,1]]},"DOI":"10.1038\/sj.bmt.1702094","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:35:32Z","timestamp":1031153732000},"page":"31-34","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Autologous stem cell transplantation for advanced Hodgkin's disease in children"],"prefix":"10.1038","volume":"25","author":[{"given":"A","family":"Verdeguer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Madero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Bureo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JM","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Fern\u00e1ndez-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Cubells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MA","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Spanish group for BMT in children (GETMON) Spain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,1,25]]},"reference":[{"key":"BF1702094_CR1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1182\/blood.V83.5.1193.1193","volume":"83","author":"DE Reece","year":"1994","unstructured":"Reece DE, Connors JM, Spinelli JJ et al. Intensive therapy with cyclophosphamide, carmustine, etoposide \u00b1 cisplatin and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy Blood 1994 83: 1193\u20131199","journal-title":"Blood"},{"key":"BF1702094_CR2","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V85.5.1381.bloodjournal8551381","volume":"85","author":"A Nademanee","year":"1995","unstructured":"Nademanee A, O'Donnell MR, Synder DS et al. High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and\/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors Blood 1995 85: 1381\u20131390","journal-title":"Blood"},{"key":"BF1702094_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/oxfordjournals.annonc.a010542","volume":"7","author":"PJ Biermann","year":"1996","unstructured":"Biermann PJ, Anderson JR, Freeman MB et al. High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy Ann Oncol 1996 7: 151\u2013156","journal-title":"Ann Oncol"},{"key":"BF1702094_CR4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood.V89.3.801","volume":"89","author":"SJ Horning","year":"1997","unstructured":"Horning SJ, Chao NJ, Negrin RS et al. High-dose therapy and autologous hematopoietic progenitor cell transplant for recurrent or refractory Hodgkin's disease: analysis of Stanford University results and prognostic indices Blood 1997 89: 801\u2013813","journal-title":"Blood"},{"key":"BF1702094_CR5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.V89.3.814","volume":"89","author":"AR Yuen","year":"1997","unstructured":"Yuen AR, Rosenberg SA, Hoppe RT et al. Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease Blood 1997 89: 814\u2013822","journal-title":"Blood"},{"key":"BF1702094_CR6","first-page":"13","volume":"16","author":"LJ Burns","year":"1995","unstructured":"Burns LJ, Daniels KA, McGlave PB . Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: factors predictive of prolonged survival Bone Marrow Transplant 1995 16: 13\u201318","journal-title":"Bone Marrow Transplant"},{"key":"BF1702094_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/10428199609067581","volume":"21","author":"AM Carella","year":"1996","unstructured":"Carella AM, Prencipe E, Pungolino E et al. Twelve years\u2019 experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP\/ABVD protocol Leuk Lymphoma 1996 21: 63\u201370","journal-title":"Leuk Lymphoma"},{"key":"BF1702094_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/10428199609051616","volume":"20","author":"J Fleurys","year":"1996","unstructured":"Fleurys J, Legros M, Colombart P et al. High-dose therapy and autologous bone marrow transplantation in first complete remission or partial response for poor prognosis Hodgkin's disease Leuk Lymphoma 1996 20: 259\u2013266","journal-title":"Leuk Lymphoma"},{"key":"BF1702094_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/10428199509052707","volume":"15","author":"SJ Bradley","year":"1996","unstructured":"Bradley SJ, Pearce R, Taghipour G et al. First remission autologous bone marrow transplantation for Hodgkin's disease. Preliminary EBMT data Leuk Lymphoma 1996 15: (Suppl.1) 51\u201353","journal-title":"Leuk Lymphoma"},{"key":"BF1702094_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.bmt.1700886","volume":"20","author":"A Sureda","year":"1997","unstructured":"Sureda A, Mataix R, Hern\u00e1ndez-Navarro F et al. Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission. A retrospective study from the Spanish GEL-TAMO cooperative group Bone Marrow Transplant 1997 20: 283\u2013288","journal-title":"Bone Marrow Transplant"},{"key":"BF1702094_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1200\/JCO.1998.16.3.897","volume":"16","author":"RJ Hutchinson","year":"1998","unstructured":"Hutchinson RJ, Fryer CJH, Davis PCh . MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group phase III trial J Clin Oncol 1998 16: 897\u2013906","journal-title":"J Clin Oncol"},{"key":"BF1702094_CR12","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1200\/JCO.1994.12.10.2160","volume":"12","author":"SP Hunger","year":"1994","unstructured":"Hunger SP, Link MP, Donaldson SS . ABVD\/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience J Clin Oncol 1994 12: 2160\u20132166","journal-title":"J Clin Oncol"},{"key":"BF1702094_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1200\/JCO.1997.15.2.528","volume":"15","author":"V Bonfante","year":"1997","unstructured":"Bonfante V, Santoro A, Viviani S et al. Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD J Clin Oncol 1997 15: 528\u2013534","journal-title":"J Clin Oncol"},{"key":"BF1702094_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/sj.bmt.1701186","volume":"21","author":"R Arranz","year":"1998","unstructured":"Arranz R, Tom\u00e1s JF, Gil-Fern\u00e1ndez JJ et al. Autologous stem cell transplantation (ASCT) for poor prognostic Hodgkin's disease (HD): comparative results with two CBV regimens and importance of disease status at transplant Bone Marrow Transplant 1998 21: 779\u2013786","journal-title":"Bone Marrow Transplant"},{"key":"BF1702094_CR15","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1200\/JCO.1993.11.4.704","volume":"11","author":"M Crump","year":"1993","unstructured":"Crump M, Smith AM, Brandwein J et al. High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant J Clin Oncol 1993 11: 704\u2013711","journal-title":"J Clin Oncol"},{"key":"BF1702094_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1200\/JCO.1999.17.3.825","volume":"17","author":"KS Baker","year":"1999","unstructured":"Baker KS, Gordon BG, Gross TG et al. Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents J Clin Oncol 1999 17: 825\u2013831","journal-title":"J Clin Oncol"},{"key":"BF1702094_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/sj.bmt.1701174","volume":"21","author":"P Moreau","year":"1998","unstructured":"Moreau P, Fleury J, Brice P et al. Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry Bone Marrow Transplant 1998 21: 787\u2013793","journal-title":"Bone Marrow Transplant"},{"key":"BF1702094_CR18","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1200\/JCO.1996.14.5.1442","volume":"14","author":"R Sankila","year":"1896","unstructured":"Sankila R, Garvicz S, Olsen JH et al. Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries J Clin Oncol 1896 14: 1442\u20131446","journal-title":"J Clin Oncol"},{"key":"BF1702094_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1200\/JCO.1998.16.2.536","volume":"16","author":"SL Wolden","year":"1998","unstructured":"Wolden SL, Lamborn KR, Cleary SF . Second cancers following pediatric Hodgkin's disease J Clin Oncol 1998 16: 536\u2013544","journal-title":"J Clin Oncol"},{"key":"BF1702094_CR20","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V83.12.3780.3780","volume":"83","author":"JS Miller","year":"1994","unstructured":"Miller JS, Arthur DC, Litz CE et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy Blood 1994 83: 3780\u20133786","journal-title":"Blood"},{"key":"BF1702094_CR21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood.V81.5.1137.1137","volume":"81","author":"R Chopra","year":"1993","unstructured":"Chopra R, McMillan AK, Linch DC et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single center eight-year study of 155 patients Blood 1993 81: 1137\u20131145","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702094","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:30:29Z","timestamp":1648071029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1,1]]}},"alternative-id":["BF1702094"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702094","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2000,1,1]]},"assertion":[{"value":"29 March 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}